Drug · DIN 02489252
ONPATTRO
LIPID COMPLEX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 25, 2019; first marketed July 25, 2019.
- Drug Identification Number (DIN)
- 02489252
- Company (DIN owner)
- Alnylam Netherlands B.V.Amsterdam, Netherlands
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Patisiran N07XX12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PATISIRAN (PATISIRAN SODIUM) | 2 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 7, 2019: NOC 22251New Drug Submission (NDS)